What to Watch For in FedEx’s Q1 Report
FedEx is set to release its quarterly results after the markets close on Monday and analysts are looking for strong year-over-year growth.
All Work
Chris Lange
How Amazon Is Breaking Into Small Business
Amazon shares dipped on Monday after it was announced that the e-commerce empire was opening a new store for customers to shop exclusively from U.S. small and medium-sized businesses selling on Amazon.
What to Expect When Oracle Reports After the Close
Oracle is scheduled to release its most recent quarterly results after the markets close on Monday.
How Starbucks Is Saving Some Green With Its New Store Initiative
Starbucks is planning to open 10,000 new "greener stores" by 2025 as part of its green initiative. The coffee giant announced earlier this summer that it was doing away with plastic straws.
Urovant Closes in on IPO
Clinical-stage biopharmaceutical company Urovant Sciences intends to price 10 million shares for an initial public offering valued up to $184 million.
How Teva Won FDA Approval for Ajovy
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
Oracle, Micron, FedEx and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Oracle, Micron, FedEx and some of the other companies that are about to report their quarterly results.
Did Constellation Overpay for Its Marijuana Experiment?
While it seems Constellation Brands made a solid move into the “cannabis space,” analysts don’t think as highly of the deal.
What Analysts Are Saying After Adobe’s Record Report
Adobe Systems shares reached an all-time high in Friday’s session following a record earnings report. Overall everything seemed to go right in this report with revenues hitting a record level.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a flat day for the broad U.S. markets. Crude oil made a small recovery back towards $70. The S&P 500 sectors were mostly negative.
Principia Biopharma Adds Even More Shares to IPO
Principia Biopharma now intends to price more than 6 million shares for an initial public offering valued up to more than $122 million.
Sears Shocks in Q2 Despite Massive Loss
Sears Holdings reported its fiscal second-quarter financial results after the markets closed on Thursday. In a surprising reaction to these results, investors sent shares higher even though this retail chain is on its last…
What This FDA Approval Means for STAAR Surgical
STAAR Surgical shares made a handy gain on Friday after the firm announced a key approval by the FDA.
Allogene Therapeutics Files for IPO
Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering.
Why Dave & Buster’s Earnings Are So Great
Dave & Buster’s reported better-than-expected fiscal second-quarter financial results before the markets opened on Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets. Crude oil took a big step back below $70. The S&P 500 sectors were more or less split down the middle.
Why Impinj Shares Are Booming
Impinj shares soared after it released its fiscal second-quarter earnings report late on Wednesday.
Is Fitbit in Trouble With Apple’s New Watch?
Fitbit shares bounced back in Thursday’s session after posting a loss of nearly 7% on Wednesday in regards to the Apple presentation for its fall product lineup.
Can Acorda Therapeutics Get Past This FDA Move?
Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User Fee Act goal date for its review of the New Drug Application of Inbrija.
Why Tailored Brands Is Thursday’s Big Earnings Winner
Tailored Brands shares rallied after it released its fiscal second-quarter financial results late on Wednesday.